A carregar...
Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients
AIM: Dolutegravir is the newest integrase inhibitor approved for HIV treatment and has demonstrated potent antiviral activity in patient populations with a broad range of treatment experience. This analysis aimed to characterize the population pharmacokinetics of dolutegravir in treatment-naive pati...
Na minha lista:
| Publicado no: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4574835/ https://ncbi.nlm.nih.gov/pubmed/25819132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12639 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|